Aster DM Quality Care Q1 FY27: Strong Start Post-Merger

Proforma Revenue (Merged Entity): ₹2,597 Cr
Operating EBITDA (Merged Entity): ₹576 Cr

Reader Takeaway: Revenue and EBITDA growth are strong, but investors await audited financials and synergy realization.

What just happened

The merged entity of Aster DM Quality Care has reported its first proforma financial results for the quarter ended September 30, 2026 (Q1 FY27), showing robust growth. Proforma revenue increased by 20% year-on-year to ₹2,597 crore, while operating EBITDA grew by 30% to ₹576 crore. The operating EBITDA margin improved by 170 basis points to 22.2%.

Why this matters

These results offer the first glimpse into the combined operational and financial strength of Aster DM Quality Care following its merger, which became effective on July 1, 2026. The positive growth in revenue and profitability, along with an improved occupancy rate and return on capital employed, signals an effective integration process and lays the groundwork for future expansion.

The backstory

The merger aimed to create a larger, more integrated healthcare provider. This quarter's performance provides initial validation of the strategic rationale behind the combination. Management highlighted that the merger has proceeded with zero operational friction.

What changes now

The company now operates 39 hospitals across 28 cities, with a total of 10,559 operational beds. The occupancy rate stands at 64%, an improvement of 510 bps year-on-year. A strategic expansion plan targets 15,077 beds by FY30, adding 4,179 beds through new and existing facilities.

Risks to watch

A key watch point is the finalization of the audit for the financial statements, as the reported figures are proforma. The company has indicated a disclaimer regarding the audit finalization, meaning actual results could differ. Management is focused on realizing synergies from the merger, with 10 identified levers expected to yield a 10-15% EBITDA uplift.

Peer comparison

While specific peer data for the proforma merged entity is not detailed in the filing, the reported EBITDA margin of 22.2% and occupancy of 64% are key metrics to track against other large hospital chains in India.

Context metrics (time-bound)

Total patient volume reached 2.01 million in Q1 FY27. RoCE stood at 22.9%, an improvement of 246 bps. The company aims to add 4,179 beds by FY30, increasing its total capacity to 15,077.

What to track next

Investors will be closely monitoring the realization of identified synergies, the final audited financial results for Q1 FY27, and progress on the bed capacity expansion targets.